Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrice Nony

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Clinical Pharmacokinetics|February 5, 2002
Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor complianceJean-Pierre Boissel, Patrice Nony
Clinical Pharmacokinetics|May 31, 2002
Use of sensitivity functions to characterise and compare the forgiveness of drugsPatrice Nony, Jean-Pierre Boissel
Therapie|March 12, 2020
A methodological framework for drug development in rare diseases. The CRESim program: Epilogue and perspectivesPatrice Nony, Behrouz Kassai, Catherine Cornu, et al.
The American Journal of Medicine|June 7, 2011
Women were included twice in a meta-analysisCatherine Cornu, Patrice Nony, Evelyne Joubert
The American Journal of Cardiology|January 3, 2015
Erroneous event count in a meta-analysis (dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus)Marielle Buisson, Catherine Cornu, Patrice Nony
Emerging Themes in Epidemiology|February 19, 2009
Revisiting the relationship between baseline risk and risk under treatmentHao Wang, Jean-Pierre Boissel, Patrice Nony
Plos One|November 4, 2015
High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular PreventionIvanny Marchant, Jean-Pierre Boissel, Patrice Nony, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectorisSylvie Chabaud, Pascal Girard, Patrice Nony, et al.
Mathematical Biosciences|May 3, 2022
Combining mathematical modeling and deep learning to make rapid and explainable predictions of the patient-specific response to anticoagulant therapy under venous flowAnass Bouchnita, Patrice Nony, Jean-Pierre Llored, et al.
Plos One|July 30, 2020
A mathematical model to quantify the effects of platelet count, shear rate, and injury size on the initiation of blood coagulation under venous flow conditionsAnass Bouchnita, Kirill Terekhov, Patrice Nony, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Clinical Pharmacokinetics|February 5, 2002
Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor complianceJean-Pierre Boissel, Patrice Nony
Clinical Pharmacokinetics|May 31, 2002
Use of sensitivity functions to characterise and compare the forgiveness of drugsPatrice Nony, Jean-Pierre Boissel
Therapie|March 12, 2020
A methodological framework for drug development in rare diseases. The CRESim program: Epilogue and perspectivesPatrice Nony, Behrouz Kassai, Catherine Cornu, et al.
The American Journal of Medicine|June 7, 2011
Women were included twice in a meta-analysisCatherine Cornu, Patrice Nony, Evelyne Joubert
The American Journal of Cardiology|January 3, 2015
Erroneous event count in a meta-analysis (dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus)Marielle Buisson, Catherine Cornu, Patrice Nony
Emerging Themes in Epidemiology|February 19, 2009
Revisiting the relationship between baseline risk and risk under treatmentHao Wang, Jean-Pierre Boissel, Patrice Nony
Plos One|November 4, 2015
High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular PreventionIvanny Marchant, Jean-Pierre Boissel, Patrice Nony, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2003
Clinical trial simulation using therapeutic effect modeling: application to ivabradine efficacy in patients with angina pectorisSylvie Chabaud, Pascal Girard, Patrice Nony, et al.
Mathematical Biosciences|May 3, 2022
Combining mathematical modeling and deep learning to make rapid and explainable predictions of the patient-specific response to anticoagulant therapy under venous flowAnass Bouchnita, Patrice Nony, Jean-Pierre Llored, et al.
Plos One|July 30, 2020
A mathematical model to quantify the effects of platelet count, shear rate, and injury size on the initiation of blood coagulation under venous flow conditionsAnass Bouchnita, Kirill Terekhov, Patrice Nony, et al.
Pageof 5